| Asuragen, Inc. - Medical Equipment - Deals and | | | | Biogen Idec |
| Alliances Profile is an essential source for company | | | | Scope |
| data and information. The profile examines the | | | | - Provides key company information for business |
| company's key business structure and operations, | | | | intelligence needs |
| history and products, and provides summary | | | | - Gives information on the company's major |
| analysis of its key revenue lines and strategy as | | | | recent financial deals including mergers & |
| well as highlighting the company's major recent | | | | acquisitions, asset transactions, PE/VC deals, |
| financial deals. | | | | equity offerings, debt offerings and partnerships. |
| Asuragen, Inc. (Asuragen) is engaged in the | | | | - Data is supplemented with details on the |
| development of clinical products for life sciences | | | | company's history, key executives, business |
| and in-vitro diagnostic markets. Its product | | | | description, locations and subsidiaries as well as a |
| portfolio includes genetic testing and oncology | | | | list of products and services and the latest |
| testing products, beadchips, cystic fibrosis | | | | available company statement. |
| screening products and diagnostic products. It also | | | | Reasons to buy |
| offers a range of services such as gene | | | | - A quick "one-stop-shop" to understand the |
| expression profiling, microRNA expression profiling, | | | | company. |
| data analysis and bioinformatics support and | | | | - Support sales activities by understanding your |
| nucleic acid isolation that are used in clinical | | | | customers' businesses. |
| research studies, pharmacogenomics and | | | | - Qualify prospective partners and suppliers. |
| biomarker discovery. The company has three | | | | - Understand and respond to your competitors' |
| business units namely Diagnostics, Therapeutics | | | | business structure, strategy and prospects |
| and Pharmacogenomic services. | | | | through. |
| And More inside the report… | | | | - Understanding the key deals which have shaped |
| Recent Developments | | | | the company. |
| Nov 19, 2009: Asuragen Forms Alliance With Life | | | | Company Mentioned |
| Technologies To Develop And Distribute | | | | The following companies are the major |
| Diagnostic Test For Chronic Myeloid Leukemia | | | | competitors of Asuragen, Inc.: |
| Jul 20, 2009: Asuragen, Biogen Ink Agreement To | | | | Seattle Genetics, Inc. |
| Pursue Integrated Drug-diagnostic | | | | Bionostics, Inc. |
| Co-development Strategy | | | | Applied Imaging Corp. |
| Jul 20, 2009: Asuragen Signs Agreement With | | | | |